270 related articles for article (PubMed ID: 30355096)
21. Vitamin K antagonists for stroke prevention in hemodialysis patients with atrial fibrillation: A systematic review and meta-analysis.
Van Der Meersch H; De Bacquer D; De Vriese AS
Am Heart J; 2017 Feb; 184():37-46. PubMed ID: 27892885
[TBL] [Abstract][Full Text] [Related]
22. Clinical presentation, diagnostic findings and management of cerebral ischemic events in patients on treatment with non-vitamin K antagonist oral anticoagulants - A systematic review.
Meinel TR; Frey S; Arnold M; Kendroud S; Fischer U; Kaesmacher J; Heldner MR; Jung S
PLoS One; 2019; 14(3):e0213379. PubMed ID: 30925155
[TBL] [Abstract][Full Text] [Related]
23. Safety of Recanalization Therapy in Patients with Acute Ischemic Stroke Under Anticoagulation: A Systematic Review and Meta-Analysis.
Liu M; Zheng Y; Li G
J Stroke Cerebrovasc Dis; 2018 Sep; 27(9):2296-2305. PubMed ID: 30017747
[TBL] [Abstract][Full Text] [Related]
24. Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
Singer DE; Albers GW; Dalen JE; Fang MC; Go AS; Halperin JL; Lip GYH; Manning WJ
Chest; 2008 Jun; 133(6 Suppl):546S-592S. PubMed ID: 18574273
[TBL] [Abstract][Full Text] [Related]
25. INR variability in atrial fibrillation: a risk model for cerebrovascular events.
Amouyel P; Mismetti P; Langkilde LK; Jasso-Mosqueda G; Nelander K; Lamarque H
Eur J Intern Med; 2009 Jan; 20(1):63-9. PubMed ID: 19237095
[TBL] [Abstract][Full Text] [Related]
26. The rs2108622 polymorphism is related to the early risk of ischemic stroke in non-valvular atrial fibrillation subjects under oral anticoagulation.
Colàs-Campàs L; Royo JL; Montserrat MV; Marzo C; Molina-Seguín J; Benabdelhak I; Cambray S; Purroy F
Pharmacogenomics J; 2018 Sep; 18(5):652-656. PubMed ID: 29273767
[TBL] [Abstract][Full Text] [Related]
27. The safety and efficacy of vitamin K antagonist in patients with atrial fibrillation and liver cirrhosis.
Lee SJ; Uhm JS; Kim JY; Pak HN; Lee MH; Joung B
Int J Cardiol; 2015 Feb; 180():185-91. PubMed ID: 25463361
[TBL] [Abstract][Full Text] [Related]
28. Vitamin K antagonist-associated intracerebral hemorrhage: lessons from a devastating disease in the dawn of the new oral anticoagulants.
Suárez-Pinilla M; Fernández-Rodríguez Á; Benavente-Fernández L; Calleja-Puerta S
J Stroke Cerebrovasc Dis; 2014 Apr; 23(4):732-42. PubMed ID: 23954605
[TBL] [Abstract][Full Text] [Related]
29. Vitamin K antagonists in patients with nonvalvular atrial fibrillation: appropriateness and quality of treatment in an Italian cohort.
Pereira de Sousa L; Burba I; Ruperto C; Lattuada L; Barbone F; Di Chiara A
J Cardiovasc Med (Hagerstown); 2013 Jul; 14(7):534-40. PubMed ID: 23328227
[TBL] [Abstract][Full Text] [Related]
30. Benefits and harms of 4-factor prothrombin complex concentrate for reversal of vitamin K antagonist associated bleeding: a systematic review and meta-analysis.
Brekelmans MPA; Ginkel KV; Daams JG; Hutten BA; Middeldorp S; Coppens M
J Thromb Thrombolysis; 2017 Jul; 44(1):118-129. PubMed ID: 28540468
[TBL] [Abstract][Full Text] [Related]
31. Adequacy of preadmission oral anticoagulation with vitamin K antagonists and ischemic stroke severity and outcome in patients with atrial fibrillation.
Tziomalos K; Giampatzis V; Bouziana SD; Spanou M; Kostaki S; Papadopoulou M; Dourliou V; Sofogianni A; Savopoulos C; Hatzitolios AI
J Thromb Thrombolysis; 2016 Feb; 41(2):336-42. PubMed ID: 26253707
[TBL] [Abstract][Full Text] [Related]
32. Anticoagulation Reversal Strategies for Left Ventricular Assist Device Patients Presenting with Acute Intracranial Hemorrhage.
Wong JK; Chen PC; Falvey J; Melvin AL; Lidder AK; Lowenstein LM; Miranpuri AS; Knight PA; Massey HT
ASAIO J; 2016; 62(5):552-7. PubMed ID: 27347708
[TBL] [Abstract][Full Text] [Related]
33. Ischemic stroke in patients with atrial fibrillation receiving oral anticoagulation.
Pujol Lereis VA; Ameriso S; Povedano GP; Ameriso SF
J Neurol Sci; 2013 Nov; 334(1-2):139-42. PubMed ID: 24054537
[TBL] [Abstract][Full Text] [Related]
34. Selection, management, and outcome of vitamin K antagonist-treated patients with atrial fibrillation not switched to novel oral anticoagulants. Results from the Dresden NOAC registry.
Michalski F; Tittl L; Werth S; Hänsel U; Pannach S; Sahin K; Weiss N; Beyer-Westendorf J
Thromb Haemost; 2015 Nov; 114(5):1076-84. PubMed ID: 25994496
[TBL] [Abstract][Full Text] [Related]
35. Safety of Statin Pretreatment in Intravenous Thrombolysis for Acute Ischemic Stroke.
Tsivgoulis G; Kadlecová P; Kobayashi A; Czlonkowska A; Brozman M; Švigelj V; Csiba L; Kõrv J; Demarin V; Vilionskis A; Jatuzis D; Katsanos AH; Rudolf J; Krespi Y; Mikulik R
Stroke; 2015 Sep; 46(9):2681-4. PubMed ID: 26173726
[TBL] [Abstract][Full Text] [Related]
36. Proposed approach to thrombolysis in dabigatran-treated patients presenting with ischemic stroke.
Kate M; Szkotak A; Witt A; Shuaib A; Butcher K
J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1351-5. PubMed ID: 24406026
[TBL] [Abstract][Full Text] [Related]
37. Effectiveness of Nonvitamin K Antagonist Oral Anticoagulants and Warfarin for Preventing Further Cerebral Microbleeds in Acute Ischemic Stroke Patients with Nonvalvular Atrial Fibrillation and At Least One Microbleed: CMB-NOW Multisite Pilot Trial.
Yokoyama M; Mizuma A; Terao T; Tanaka F; Nishiyama K; Hasegawa Y; Nagata E; Nogawa S; Kobayashi H; Yanagimachi N; Okazaki T; Kitagawa K; Takizawa S;
J Stroke Cerebrovasc Dis; 2019 Jul; 28(7):1918-1925. PubMed ID: 31005561
[TBL] [Abstract][Full Text] [Related]
38. Successful intravenous thrombolysis for ischemic stroke after reversal of dabigatran anticoagulation with idarucizumab: a case report.
Agosti S; Casalino L; Rocci E; Zaccone G; Rota E
J Med Case Rep; 2017 Aug; 11(1):224. PubMed ID: 28806993
[TBL] [Abstract][Full Text] [Related]
39. Stroke Care and Application of Thrombolysis in Ibero-America: Report From the SITS-SIECV Ibero-American Stroke Register.
Alonso de Leciñana M; Mazya MV; Kostulas N; Del Brutto OH; Abanto C; Massaro AR; de Bastos M; Martins S; Ameriso SF; Gongora-Rivera F; Sacks C; Hoppe A; Abad P; Meza G; Arauz-Gongora A; Wahlgren N; Díez-Tejedor E;
Stroke; 2019 Sep; 50(9):2507–2512. PubMed ID: 31670921
[TBL] [Abstract][Full Text] [Related]
40. Trends in oral anticoagulant choice for acute stroke patients with nonvalvular atrial fibrillation in Japan: the SAMURAI-NVAF study.
Toyoda K; Arihiro S; Todo K; Yamagami H; Kimura K; Furui E; Terasaki T; Shiokawa Y; Kamiyama K; Takizawa S; Okuda S; Okada Y; Kameda T; Nagakane Y; Hasegawa Y; Mochizuki H; Ito Y; Nakashima T; Takamatsu K; Nishiyama K; Kario K; Sato S; Koga M;
Int J Stroke; 2015 Aug; 10(6):836-42. PubMed ID: 25581108
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
